| 1 |
33196511 | A pilot randomized trial of atorvastatin as adjunct therapy in patients with acute venous thromboembolism. | 2021 Jan 1 |
3 |
| 2 |
32126886 | Statin treatment of patients with calcific aortic valve disease modulates extracellular adenosine metabolism on the cell surface of the aortic valve. | 2020 |
2 |
| 3 |
23555637 | Inhibition of Rho and Rac geranylgeranylation by atorvastatin is critical for preservation of endothelial junction integrity. | 2013 |
1 |
| 4 |
23903277 | [Statin and clopidogrel pharmacological interaction]. | 2013 Sep |
1 |
| 5 |
21052830 | Atorvastatin neutralises the thrombin-induced tissue factor expresion in endothelial cells via geranylgeranyl pyrophosphate. | 2011 Jan |
4 |
| 6 |
21614411 | Atorvastatin reduces thrombin generation and expression of tissue factor, P-selectin and GPIIIa on platelet-derived microparticles in patients with peripheral arterial occlusive disease. | 2011 Aug |
3 |
| 7 |
20441243 | Effect of atorvastatin on haemostasis, fibrinolysis and inflammation in normocholesterolaemic patients with coronary artery disease: a post hoc analysis of data from a prospective, randomized, double-blind study. | 2010 |
1 |
| 8 |
19237515 | Human platelets express organic anion-transporting peptide 2B1, an uptake transporter for atorvastatin. | 2009 May |
3 |
| 9 |
17922340 | Atorvastatin neutralizes the up-regulation of thrombospondin-1 induced by thrombin in human umbilical vein endothelial cells. | 2007 Jul-Oct |
4 |
| 10 |
15640525 | Thrombin-induced rapid geranylgeranylation of RhoA as an essential process for RhoA activation in endothelial cells. | 2005 Mar 18 |
5 |
| 11 |
15687128 | Short-term treatment with atorvastatin reduces platelet CD40 ligand and thrombin generation in hypercholesterolemic patients. | 2005 Feb 1 |
2 |
| 12 |
15792677 | Atorvastatin reduces thrombin generation after percutaneous coronary intervention independent of soluble tissue factor. | 2005 |
1 |
| 13 |
15193831 | Effect of atorvastatin on different fibrinolyis mechanisms in hypercholesterolemic subjects. | 2004 Jun |
3 |